A new system is being developed to test drugs that could improve efficiency and decrease the amount of time it takes for drugs to get to the market. MIT has received a grant from Defense Advanced Research Projects Agency (DARPA) and the National Institutes of Health (NIH) to develop a Human Tissue Simulator with the University's Department of Biological Engineering. With this technology, drugs can be tested immediately on engineered human tissue constructs. According to Lilly Clinical Open Innovation, They will be in chips that hold 10 molecules each which will allow for immediate drug testing. The project's goal is to increase targeted trial design, increase the target for populations.
This is just one of the many ways clinical trials are improving. This April at Partnerships in Clinical Trials, we will be looking at how companies cam partner and develop more efficient clinical trial processes. The program is still in production, but you can sign up to receive updates and be notified as soon as the agenda is available.
What do you think testing molecules on a human tissue simulator can do for clinical trials? Do you think this will speed up the rate of clinical trials?
The Partnerships in Clinical Trials Blog focuses on optimization intelligence, regulatory trends and globalization strategies for both sponsors and CROs. It is supported by a number of industry events.
Would you like to guest blog on our site? Or send us feedback? Send an email to firstname.lastname@example.org.